THE ORGANIZATION'S MISSION IS FOCUSED ON THE DEVELOPMENT OF TREATMENTS AND CURES FOR RETT SYNDROME AND RELATED MECP2 DISORDERS.
Executive compensation, broken down
Form 990 · Part VII & Schedule J · 4 reported individuals · Filing year 2024
Percentile bands compare each position's total pay with the same role at Health Care organizations nationwide.
- Base
- $220k
- Bonus
- —
- Other
- —
- Benefits
- —
- Base
- $220k
- Bonus
- —
- Other
- —
- Benefits
- —
- Base
- $220k
- Bonus
- —
- Other
- —
- Benefits
- —
- Base
- $215k
- Bonus
- —
- Other
- —
- Benefits
- —
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
Chief Scientific Officer Key Employee 25th percentile to median | $220k | — | — | — | $220k $238k |
Chief Executive Officer Median to 75th percentilevs Health Care peers in Connecticut | $220k | — | — | — | $220k $238k |
Chief Development Officer Median to 75th percentile | $220k | — | — | — | $220k $238k |
Chief Technology Officer Key Employee 25th percentile to median | $215k | — | — | — | $215k $232k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with BLS CPI-U for the Northeast region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 12 unpaid individuals.
Top pay as a share of expenses
In 2024, the highest total compensation at RETT SYNDROME RESEARCH TRUST INC equaled 2% of the organization's total expenses. The median for health care organizations is 4%.
Based on 13,830 health care organizations, each measured at its most recent filing year with reported expenses and compensation.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
Held steady
from 2023
From $220k in 2023 to $220k in 2024.
Estimated with BLS CPI-U for the Northeast region, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Chief Executive Officer pay held roughly steady from 2023 to 2024, while revenue rose 9%.
- Chief Development Officer pay held roughly steady from 2023 to 2024.
Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Common questions about RETT SYNDROME RESEARCH TRUST INC
What does the Key Employee of RETT SYNDROME RESEARCH TRUST INC earn?
In 2024, the Key Employee of RETT SYNDROME RESEARCH TRUST INC received $220,000 in total compensation. This pay is below the median (the midpoint) for Key Employee roles among Health Care organizations nationwide, but above the bottom quarter of comparable filings. Based on IRS Form 990 data.
How does Key Employee pay at RETT SYNDROME RESEARCH TRUST INC compare with similar nonprofits?
Compared with the same role at Health Care organizations nationwide, the 2024 pay of the Key Employee at RETT SYNDROME RESEARCH TRUST INC falls between the 25th percentile and the median. In 2024, the highest total compensation at RETT SYNDROME RESEARCH TRUST INC equaled 2% of the organization's total expenses. The median for health care organizations is 4%.
What are RETT SYNDROME RESEARCH TRUST INC's revenue and expenses?
In 2024, RETT SYNDROME RESEARCH TRUST INC reported $9.3M in total revenue and $11.7M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more